ArticleCancers2019

Uptake of Ranibizumab but Not Bevacizumab into Uveal Melanoma Cells Correlates with a Sustained Decline in VEGF-A Levels and Metastatic Activities.

Aysegül Tura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.